Showing results (51-60 of 192) with videos related to
Sort By:
Pageof 20
Nature Communications|March 7, 2020
Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendantsXiang Shu, Jirong Long, Qiuyin Cai, et al.Breast Cancer Research and Treatment|April 13, 2020
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohortsDaniele Giardiello, Michael Hauptmann, Ewout W Steyerberg, et al.Cancer Research|April 12, 2015
Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density MeasuresJennifer Stone, Deborah J Thompson, Isabel Dos Santos Silva, et al.Nature Communications|July 8, 2021
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry womenBabatunde Adedokun, Zhaohui Du, Guimin Gao, et al.Iscience|February 24, 2026
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancerAaron J Bernstein, Renske Keeman, Amber N Hurson, et al.Journal of the National Cancer Institute|June 20, 2022
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based StudiesAudrey Y Jung, Thomas U Ahearn, Sabine Behrens, et al.Cancer Research Communications|October 28, 2022
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 womenXiaoliang Wang, Hongjie Chen, Pooja Middha Kapoor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.Nature Communications|August 2, 2020
European polygenic risk score for prediction of breast cancer shows similar performance in Asian womenWeang-Kee Ho, Min-Min Tan, Nasim Mavaddat, et al.NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.Pageof 20